Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $11,709 | 503 | 88.0% |
| Consulting Fee | $1,390 | 1 | 10.5% |
| Education | $179.00 | 11 | 1.3% |
| Travel and Lodging | $23.58 | 1 | 0.2% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| AstraZeneca Pharmaceuticals LP | $1,475 | 76 | $0 (2024) |
| Genentech USA, Inc. | $1,414 | 2 | $0 (2023) |
| Amgen Inc. | $1,344 | 59 | $0 (2024) |
| Novo Nordisk Inc | $1,078 | 53 | $0 (2024) |
| SANOFI-AVENTIS U.S. LLC | $732.60 | 30 | $0 (2022) |
| Lilly USA, LLC | $692.88 | 42 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $520.71 | 13 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $446.72 | 27 | $0 (2024) |
| Janssen Pharmaceuticals, Inc | $402.51 | 14 | $0 (2021) |
| Amarin Pharma Inc. | $394.06 | 24 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,708 | 48 | Inspire Medical Systems, Inc. ($276.99) |
| 2023 | $2,323 | 40 | Genentech USA, Inc. ($1,414) |
| 2022 | $1,207 | 52 | Abbott Laboratories ($172.42) |
| 2021 | $937.73 | 53 | Lilly USA, LLC ($158.78) |
| 2020 | $1,186 | 56 | Medtronic Vascular, Inc. ($148.89) |
| 2019 | $1,768 | 80 | AstraZeneca Pharmaceuticals LP ($252.24) |
| 2018 | $2,281 | 101 | AstraZeneca Pharmaceuticals LP ($373.24) |
| 2017 | $1,891 | 86 | AstraZeneca Pharmaceuticals LP ($316.14) |
All Payment Transactions
516 individual payment records from CMS Open Payments — Page 1 of 21
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/05/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $14.66 | General |
| Category: Respiratory | ||||||
| 11/21/2024 | Seqirus USA Inc | Flucelvax (Biological), Fluad | Food and Beverage | In-kind items and services | $28.43 | General |
| Category: Vaccines | ||||||
| 11/20/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $19.23 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 10/31/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $17.68 | General |
| Category: Cardio-renal | ||||||
| 10/30/2024 | Merck Sharp & Dohme LLC | GARDASIL (Biological), CAPVAXIVE, GARDASIL 9 | Food and Beverage | In-kind items and services | $20.92 | General |
| Category: VACCINE | ||||||
| 10/18/2024 | PFIZER INC. | PREVNAR 20 (Biological), COMIRNATY, ABRYSVO | Food and Beverage | In-kind items and services | $22.73 | General |
| Category: VACCINES | ||||||
| 10/16/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $16.99 | General |
| Category: Inflammation | ||||||
| 10/09/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $18.80 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 10/03/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug), AREXVY | Food and Beverage | In-kind items and services | $29.04 | General |
| Category: RESPIRATORY | ||||||
| 09/28/2024 | Inspire Medical Systems, Inc. | INSPIRE (Device) | Food and Beverage | In-kind items and services | $36.93 | General |
| Category: NEUROLOGY | ||||||
| 09/26/2024 | Azurity Pharmaceuticals, Inc. | HORIZANT (Drug) | Food and Beverage | In-kind items and services | $20.98 | General |
| Category: CEREBROVASCULARCNS | ||||||
| 09/12/2024 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $16.89 | General |
| Category: Cardiology | ||||||
| 09/11/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $24.16 | General |
| Category: DIABETES | ||||||
| 09/03/2024 | GENZYME CORPORATION | — | Food and Beverage | In-kind items and services | $130.96 | General |
| 08/29/2024 | Lilly USA, LLC | — | Food and Beverage | In-kind items and services | $20.92 | General |
| 08/21/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $22.08 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 08/15/2024 | Cardinal Health 200 LLC | — | Food and Beverage | In-kind items and services | $20.63 | General |
| 07/25/2024 | Exact Sciences Corporation | Cologuard Collection Kit (Device) | Food and Beverage | In-kind items and services | $18.93 | General |
| Category: Oncology | ||||||
| 07/21/2024 | Novo Nordisk Inc | — | Food and Beverage | In-kind items and services | $55.10 | General |
| 07/16/2024 | Novo Nordisk Inc | — | Food and Beverage | In-kind items and services | $55.10 | General |
| 07/12/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $23.75 | General |
| Category: Respiratory | ||||||
| 06/21/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $26.00 | General |
| Category: RESPIRATORY | ||||||
| 06/13/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug), FARXIGA | Food and Beverage | In-kind items and services | $29.10 | General |
| Category: Respiratory | ||||||
| 06/12/2024 | Inspire Medical Systems, Inc. | INSPIRE (Device) | Food and Beverage | In-kind items and services | $127.00 | General |
| Category: NEUROLOGY | ||||||
| 05/30/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $22.27 | General |
| Category: DIABETES | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 7 | 339 | 442 | $82,099 | $31,613 |
| 2022 | 9 | 391 | 506 | $86,544 | $35,290 |
| 2021 | 7 | 410 | 544 | $78,483 | $36,868 |
| 2020 | 9 | 604 | 748 | $70,546 | $37,156 |
All Medicare Procedures & Services
32 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 80 | 161 | $35,501 | $14,186 | 40.0% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 82 | 82 | $25,215 | $10,480 | 41.6% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 37 | 55 | $8,580 | $3,374 | 39.3% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 39 | 40 | $1,500 | $1,251 | 83.4% |
| 90674 | Influenza vaccine, quadrivalent derived from cell cultures, preservative and antibiotic free | Office | 2023 | 37 | 37 | $2,960 | $1,239 | 41.9% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 15 | 18 | $1,728 | $617.97 | 35.8% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 49 | 49 | $6,615 | $464.88 | 7.0% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 92 | 176 | $38,597 | $14,918 | 38.6% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 54 | 55 | $16,913 | $7,933 | 46.9% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 63 | 86 | $13,416 | $5,054 | 37.7% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 32 | 32 | $6,000 | $4,267 | 71.1% |
| 90756 | Influenza vaccine, quadrivalent derived from cell cultures | Office | 2022 | 39 | 39 | $1,559 | $1,169 | 75.0% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2022 | 15 | 17 | $1,632 | $615.58 | 37.7% |
| G0008 | Administration of influenza virus vaccine | Office | 2022 | 13 | 16 | $600.00 | $485.42 | 80.9% |
| 90471 | Administration of vaccine | Office | 2022 | 38 | 38 | $1,482 | $483.44 | 32.6% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2022 | 45 | 47 | $6,345 | $365.73 | 5.8% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 105 | 198 | $35,409 | $17,918 | 50.6% |
| 99215 | Established patient outpatient visit, total time 40-54 minutes | Office | 2021 | 75 | 75 | $18,983 | $9,401 | 49.5% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 56 | 88 | $10,625 | $5,772 | 54.3% |
| 90674 | Vaccine for influenza derived from cell cultures for administration into muscle, 0.5 ml dosage, quadrivalent, , preservative and antibiotic free | Office | 2021 | 55 | 56 | $4,450 | $1,677 | 37.7% |
| G0008 | Administration of influenza virus vaccine | Office | 2021 | 55 | 61 | $2,288 | $1,072 | 46.9% |
| 99212 | Established patient outpatient visit, total time 10-19 minutes | Office | 2021 | 16 | 17 | $1,284 | $554.24 | 43.2% |
| 93000 | Routine ekg using at least 12 leads including interpretation and report | Office | 2021 | 48 | 49 | $5,445 | $474.22 | 8.7% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 111 | 211 | $27,400 | $15,311 | 55.9% |
| 99215 | Established patient office or other outpatient, visit typically 40 minutes | Office | 2020 | 109 | 109 | $18,485 | $11,015 | 59.6% |
About Gary Sheppard
Gary Sheppard is a Internal Medicine healthcare provider based in Houston, Texas. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 01/12/2006. The National Provider Identifier (NPI) number assigned to this provider is 1174502702.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Gary Sheppard has received a total of $13,301 in payments from pharmaceutical and medical device companies, with $1,708 received in 2024. These payments were reported across 516 transactions from 49 companies. The most common payment nature is "Food and Beverage" ($11,709).
As a Medicare-enrolled provider, Sheppard has provided services to 1,744 Medicare beneficiaries, totaling 2,240 services with total Medicare billing of $140,927. Data is available for 4 years (2020–2023), covering 32 distinct procedure/service records.
Practice Information
- Specialty Internal Medicine
- Location Houston, TX
- Active Since 01/12/2006
- Last Updated 01/12/2011
- Taxonomy Code 207R00000X
- Entity Type Individual
- NPI Number 1174502702
Products in Payments
- Vabysmo (Drug) $1,414
- FARXIGA (Drug) $1,140
- Ozempic (Drug) $472.17
- TRULICITY (Drug) $438.33
- Vascepa (Drug) $394.06
- Repatha (Biological) $381.03
- JARDIANCE (Drug) $312.92
- Otezla (Drug) $282.18
- INSPIRE (Device) $276.99
- XARELTO (Drug) $268.01
- MYRBETRIQ (Drug) $234.09
- WATCHMAN (Device) $224.12
- Aimovig (Biological) $216.50
- ENTRESTO (Drug) $215.66
- Livalo (Drug) $213.73
- JANUVIA (Drug) $204.30
- Prolia (Biological) $178.43
- TOUJEO (Drug) $177.99
- SOLIQUA 100/33 (Biological) $176.91
- ELIQUIS (Drug) $173.57
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Houston
Stephen Pappas, M.d, M.D
Internal Medicine — Payments: $1.6M
Mohamed Othman, Md, MD
Internal Medicine — Payments: $1.1M
Dr. Aung Naing, Md, MD
Internal Medicine — Payments: $925,146
Miguel Escobar, M.d, M.D
Internal Medicine — Payments: $924,228
Dr. Christie Ballantyne, Md, MD
Internal Medicine — Payments: $815,154
John Heymach, M.d, M.D
Internal Medicine — Payments: $786,947